Healthcare Distribution Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Healthcare Distribution Market Distributors and it is Segmented by Product Type (Pharmaceutical Product Distribution Services (Over the Counter Drugs, Generic Drugs, and Branded Drugs), Biopharmaceutical Product Distribution Services (Recombinant Proteins, Monoclonal Antibodies, and Vaccines), and Medical Devices Distribution Services), End-User (Retail Pharmacies, Hospital Pharmacies, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Healthcare Distribution Market Size

Single User License


Team License


Corporate License


Book before:
Healthcare Distribution Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Healthcare Distribution Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

Healthcare Distribution Market Analysis

The healthcare distribution market is expected to register a CAGR of 6.5 % over the forecast period.

The COVID-19 pandemic was an incomparable global public health emergency. It impacted almost every industry sector, including healthcare distribution, mainly due to disruptions to the healthcare supply chain. However, the companies took various actions to manage these disruptions in the supply chain through their strategic partners and manufacturer suppliers. For instance, as per the report published by Cardinal Health in December 2021, the company worked closely with its manufacturer suppliers to help ensure a healthy supply of products. In addition, as per the same source, the company installed a new warehouse management system in many distribution centers to manage the challenges in the healthcare supply chain. As a result, the market originally had a modest negative impact but is anticipated to develop due to corporate strategies for addressing supply chain difficulties over the coming years.

With the large economic burden of chronic diseases, technological advancement in distribution, favorable R&D investment scenario, and subsequent increase in drug launches are the main driving factors of the healthcare distribution market. For instance, in 2022, the National Institution of Chronic Disease and Data reported that nearly 60% of American adults suffer from at least one chronic disease, and about 40% of adults include multiple chronic conditions (MCC). Chronic conditions like diabetes, cancer, and cardiovascular disease are the leading causes of morbidity in the United States. Hence, proper management and diagnosis of these diseases are needed with various healthcare products necessary for effective healthcare distribution services. Thus, increasing cases of chronic disease are driving the healthcare distribution market.

Technological advancements and new distribution strategies of market players are expected to boost the healthcare distribution market. For instance, in May 2022, Nippon Express Co., Ltd. launched a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry. With this, the company provided a pharmaceutical distribution platform with strict temperatures. Hence, these new platforms in healthcare distribution are expected to hold significant growth in the market over the forecast period.

However, the high cost and investment associated with healthcare distribution services are expected to hamper the overall growth of this market.

Healthcare Distribution Market Trends

Retail Pharmacy is Expected to Witness a Significant Growth Over the Forecast Period

Retail pharmacies (often known as community pharmacies) supply and sell medicine and medical-related products to the general public and medical practitioners, as well as other goods such as toiletries, cosmetics, small medical devices, and veterinary products. The retail pharmacy deals with many prescriptions and is thus expected to drive this market. In developed countries, the high availability of healthcare schemes and programs led to a significant increase in the number of prescriptions.

Furthermore, the new agreements among the market players for distributing healthcare products in retail pharmacies likely propel the market to grow. For instance, in September 2022, McKesson Corporation signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to retail and other pharmacies and distribution centers through June 2027. Similarly, in June 2022, BD (Becton, Dickinson, and Company) and Frazier Healthcare Partners entered a definitive agreement for BD to acquire Parata Systems. It is an innovative provider of pharmacy automation solutions for hospitals, retail pharmacies, and other healthcare settings. Thus, these agreements help supply healthcare products efficiently, which is expected to boost market growth.

Moreover, the growing incidence of chronic diseases like hypertension, diabetes, cardiovascular diseases, and cancer, which require prolonged medication, is directly related to increased prescriptions. It can further drive the growth of the retail pharmacy market during the forecast period. For instance, 2021 reported that about 536.6 million people were estimated to suffer from diabetes in 2021, and this number will increase to 642.7 million by 2030. Thus, the high prevalence rate of chronic diseases like diabetes increases the need for various pharmaceuticals that can be procured from retail pharmacies and is expected to grow in the segment over the forecast period.

Healthcare Distribution Market: Number of Specialty Prescriptions (In Billion), United States, 2020-2021

North America is Expected to hold Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant market share owing to factors such as the rapid expansion of the pharmaceutical and biopharmaceutical industry, rising demand for specialty drugs and generics, and large-scale adoption of advanced technologies such as Artificial Intelligence and blockchain in the healthcare sector.

The use of artificial intelligence technology boosted distribution practices globally. For instance, the article published by the journal SAGE in September 2021 summarizes that by using Artificial intelligence technology, businesses can offer shipment updates to customers. When tracking technology fails, an (Artificial Intelligence) AI system can track the delay in the delivery so companies can easily estimate delivery time to their customers. These updates on product delivery through AI increase the distribution services and likely boost the market to growth.

Furthermore, the significant number of prescriptions in the region increases the demand for various healthcare products and distribution services. For instance, as per the report published by AssureCare LLC in November 2022, in the United States, around 6.47 billion prescriptions were dispensed in 2021, which is high and is expected to increase more over the coming years. In addition, the new regional distribution agreements increase the services and likely boost the market. For instance, in March 2023, Endonovo Therapeutics, Inc. signed a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller Agreement (Agreement or Contract) with Academy Medical, Inc. of West Palm Beach, FL, to distribute SofPulse medical devices to ensure its availability to the Veterans Health Administration (VHA) and Department of Defense (DoD) contracts. Thus, increasing prescriptions and new agreements to distribute healthcare products will likely raise the demand for healthcare distribution services and boost the market growth over the forecast period.

Healthcare Distribution Market - Growth Rate by Region

Healthcare Distribution Industry Overview

The healthcare distribution market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known as McKesson Corporation, Cardinal Health, Morris and Dickson Company, Smith Drug Company, Owens and Minor Inc., Patterson Companies, PHOENIX Group, Owens, Medline Industries, and other Companies.

Healthcare Distribution Market Leaders

  1. McKesson Corporation

  2. Smith Drug Company

  3. Morris and Dickson Company

  4. Owens and Minor Inc

  5. PHOENIX Group

*Disclaimer: Major Players sorted in no particular order

Healthcare Distribution Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Healthcare Distribution Market News

  • January 2023: Amylyx Pharmaceuticals, Inc. entered into an exclusive license and distribution agreement with Neopharm. Here, Neopharm will commercialize, subject to regulatory review and approval, AMX0035 (sodium phenylbutyrate and ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS) in Israel, Gaza, West Bank, and the Palestinian Authority.
  • May 2022: AAH Pharmaceuticals, one of the market players in the wholesale distribution of medicines in the United Kingdom, partnered with RELEX Solutions. AAH Pharmaceuticals uses RELEX to manage their forecasting and replenishment with over 1,000 vendors, support demand and supply planning across multiple product categories and characteristics such as seasonality and promotional activity, and improve efficiency through delivery flow smoothing.

Healthcare Distribution Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Incidence and Large Economic Burden of Chronic Diseases

      2. 4.2.2 Technological Advancement in Distribution

      3. 4.2.3 Favorable R&D Investment Scenario, and Subsequent Increase in Drug Launches

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Healthcare Distribution

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By Product Type

      1. 5.1.1 Pharmaceutical Product Distribution Services

        1. Over The Counter Drugs

        2. Generic Drugs

        3. Branded Drugs

      2. 5.1.2 Biopharmaceutical Product Distribution Service

        1. Recombinant Proteins

        2. Monoclonal Antibodies

        3. Vaccines

      3. 5.1.3 Medical Devices Distribution Services

    2. 5.2 By End-User

      1. 5.2.1 Retail Pharmacies

      2. 5.2.2 Hospital Pharmacies

      3. 5.2.3 Other End-Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 McKesson Corporation

      2. 6.1.2 Cardinal Health

      3. 6.1.3 Morris and Dickson Company

      4. 6.1.4 Smith Drug Company

      5. 6.1.5 Owens and Minor Inc

      6. 6.1.6 Patterson Companies

      7. 6.1.7 PHOENIX Group

      8. 6.1.8 Shanghai Pharmaceutical Group

      9. 6.1.9 Medline Industries

      10. 6.1.10 CuraScript SD

      11. 6.1.11 Mutual Drug

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Healthcare Distribution Industry Segmentation

As per the scope of the market, healthcare distribution refers to entire distribution practices in the healthcare sector used for enterprise resource planning, customer relationship management, medical and pharmacy supplies, wholesaling medications, and distribution and associated services. The healthcare distribution market is segmented by product type (pharmaceutical product distribution services (over-the-counter drugs, generic drugs, and branded drugs), biopharmaceutical product distribution services (recombinant proteins, monoclonal antibodies, and vaccines), and medical devices distribution services), end-user (retail pharmacies, hospital pharmacies, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type
Pharmaceutical Product Distribution Services
Over The Counter Drugs
Generic Drugs
Branded Drugs
Biopharmaceutical Product Distribution Service
Recombinant Proteins
Monoclonal Antibodies
Medical Devices Distribution Services
By End-User
Retail Pharmacies
Hospital Pharmacies
Other End-Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America
Need A Different Region Or Segment?
Customize Now

Healthcare Distribution Market Research FAQs

The Global Healthcare Distribution Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

McKesson Corporation, Smith Drug Company, Morris and Dickson Company, Owens and Minor Inc and PHOENIX Group are the major companies operating in the Global Healthcare Distribution Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Healthcare Distribution Market.

The report covers the Global Healthcare Distribution Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Healthcare Distribution Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Healthcare Distribution Industry Report

Statistics for the 2024 Healthcare Distribution market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Healthcare Distribution analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Healthcare Distribution Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)